Related references
Note: Only part of the references are listed.Epithelial-to-mesenchymal transition of tumor cells: cancer progression and metastasis
Vasileios Vardas et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2022)
Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients
Spyridoula D. Katsarou et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis
Liping Qiu et al.
BMC CANCER (2022)
Liquid biopsies: Potential and challenges
Isabel Heidrich et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
CXCR4 uses STAT3-mediated slug expression to maintain radioresistance of non-small cell lung cancer cells: emerges as a potential prognostic biomarker for lung cancer
Jeong-Yub Kim et al.
CELL DEATH & DISEASE (2021)
Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients
Aliki Ntzifa et al.
SCIENTIFIC REPORTS (2021)
Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
Eva Obermayr et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Clinical Relevance of Mesenchymal- and Stem-Associated Phenotypes in Circulating Tumor Cells Isolated from Lung Cancer Patients
Evangelia Pantazaka et al.
CANCERS (2021)
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer
Lea Sinoquet et al.
CLINICAL CHEMISTRY (2021)
The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB
Sasithorn Wanna-udom et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review
Stepan M. Esagian et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Mechanisms and Future of Non-Small Cell Lung Cancer Metastasis
Tianhao Zhu et al.
FRONTIERS IN ONCOLOGY (2020)
CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosis
Galatea Kallergi et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment
Ippokratis Messaritakis et al.
LUNG CANCER (2019)
Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer
Vilem Maly et al.
IN VIVO (2019)
The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2019)
JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion
Anders Sundqvist et al.
NUCLEIC ACIDS RESEARCH (2018)
RAC2 promotes abnormal proliferation of quiescent cells by enhanced JUNB expression via the MAL-SRF pathway
Hailong Pei et al.
CELL CYCLE (2018)
The good and bad faces of the CXCR4 chemokine receptor
Joaquin Teixido et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
Galatea Kallergi et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment
Ippokratis Messaritakis et al.
LUNG CANCER (2018)
Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements
G. Kallergi et al.
BREAST CANCER RESEARCH (2018)
CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer
Zhenbo Tu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Transforming growth factor-β1 regulation of ATF-3, c-Jun and JunB proteins for activation of matrix metalloproteinase-13 gene in human breast cancer cells
M. Gokulnath et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study
Ravi Salgia et al.
INVESTIGATIONAL NEW DRUGS (2017)
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer
Ippokratis Messaritakis et al.
PLOS ONE (2017)
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Marianna Gallo et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs)
Galatea Kallergi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
CXCR4 signaling in health and disease
Tommaso Pozzobon et al.
IMMUNOLOGY LETTERS (2016)
JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma
Hiroshi Hyakusoku et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
XCR1 promotes cell growth and migration and is correlated with bone metastasis in non-small cell lung cancer
Ting Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis
H. Wang et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
Matthew G. Oser et al.
LANCET ONCOLOGY (2015)
PDK1 induces JunB, EMT, cell migration and invasion in human gallbladder cancer
Shixian Lian et al.
ONCOTARGET (2015)
CXCR4 over-expression and survival in cancer: A system review and meta-analysis
Hongli Zhao et al.
ONCOTARGET (2015)
Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application
Jian Yin et al.
PLOS ONE (2015)
Circulating tumor cells as promising novel biomarkers in solid cancers
Evi S. Lianidou et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2014)
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Cassandra L. Hodgkinson et al.
NATURE MEDICINE (2014)
JunB contributes to Id2 repression and the epithelial-mesenchymal transition in response to transforming growth factor-β
Megan Gervasi et al.
JOURNAL OF CELL BIOLOGY (2012)
Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
Jian-Mei Hou et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
Jian-Mei Hou et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2011)
CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer
Karen L. Reckamp et al.
BMC CANCER (2009)
Circulating tumor cells in patients with breast cancer dormancy
SD Meng et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
